company background image
HINOON logo

Highnoon Laboratories KASE:HINOON Stock Report

Last Price

PK₨824.80

Market Cap

PK₨43.7b

7D

2.6%

1Y

91.5%

Updated

01 Nov, 2024

Data

Company Financials

Highnoon Laboratories Limited

KASE:HINOON Stock Report

Market Cap: PK₨43.7b

HINOON Stock Overview

Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.

HINOON fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health5/6
Dividends4/6

Highnoon Laboratories Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Highnoon Laboratories
Historical stock prices
Current Share PricePK₨824.80
52 Week HighPK₨850.00
52 Week LowPK₨421.00
Beta0.28
11 Month Change18.00%
3 Month Change20.11%
1 Year Change91.51%
33 Year Change79.69%
5 Year Change234.75%
Change since IPO23,071.45%

Recent News & Updates

Recent updates

Shareholder Returns

HINOONPK PharmaceuticalsPK Market
7D2.6%8.9%1.0%
1Y91.5%127.6%51.0%

Return vs Industry: HINOON underperformed the PK Pharmaceuticals industry which returned 127.6% over the past year.

Return vs Market: HINOON exceeded the PK Market which returned 51% over the past year.

Price Volatility

Is HINOON's price volatile compared to industry and market?
HINOON volatility
HINOON Average Weekly Movement4.3%
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement5.7%
10% most volatile stocks in PK Market9.5%
10% least volatile stocks in PK Market3.6%

Stable Share Price: HINOON has not had significant price volatility in the past 3 months compared to the PK market.

Volatility Over Time: HINOON's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19842,295Adeel Haiderwww.highnoon-labs.com

Highnoon Laboratories Limited, together with its subsidiaries, manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products. It offers products in various therapeutic areas, including allergy, anti-infective, cardiology, gastroenterology, metabolic, musculoskeletal, obstetrics and gynaecology, paediatrics, respiratory, and urology; and generic products under various brands. The company serves Pakistan, Afghanistan, the United Arab Emirates, France, Kenya, Iraq, Cambodia, Tanzania, and internationally.

Highnoon Laboratories Limited Fundamentals Summary

How do Highnoon Laboratories's earnings and revenue compare to its market cap?
HINOON fundamental statistics
Market capPK₨43.70b
Earnings (TTM)PK₨3.02b
Revenue (TTM)PK₨23.02b

14.5x

P/E Ratio

1.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HINOON income statement (TTM)
RevenuePK₨23.02b
Cost of RevenuePK₨11.38b
Gross ProfitPK₨11.64b
Other ExpensesPK₨8.62b
EarningsPK₨3.02b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)56.98
Gross Margin50.57%
Net Profit Margin13.11%
Debt/Equity Ratio11.1%

How did HINOON perform over the long term?

See historical performance and comparison

Dividends

3.6%

Current Dividend Yield

56%

Payout Ratio